Latest Generation Random Analyzer System Unveiled at the AACC Clinical Lab Expo
By LabMedica International staff writers Posted on 01 Aug 2013 |

Image: The Siemens VersaCell X3 System (Photo courtesy of Siemens).
The latest generation random access clinical chemistry and immunochemistry analyzer is receiving its debut at the AACC (American Association for Clinical Chemistry) Clinical Lab Expo in Houston (TX, USA), from July 30-August 1, 2013.
The Siemens Healthcare Diagnostics (Tarrytown, NY, USA) is unveiling the advanced VersaCell X3 system at the Clinical Lab Expo.
The newest model of Siemens’s longstanding VersaCell System, the new VersaCell X3 Solution now offers the benefits of automation without the space or budget considerations of a track-based system. VersaCell X3 Solution’s arrival compliments the recent launch of the Siemens Aptio Automation platform, designed for the growing needs of medium- to very high-volume laboratories.
The VersaCell X3 Solution delivers several advantages. The new platform maintains its small footprint and upright design, but now connects up to three Siemens analyzers through a single robotic sample interface for increased productivity gains. By supporting a customized mix of chemistry, immunoassay and/or integrated systems and associated assay menus, VersaCell X3 Solution helps labs to reduce operator sample handling, better prioritize staff work and eliminate pre- and post-analytical processing—all through one-touch sample management.
A new priority drawer on the VersaCell X3 Solution provides eight new STAT positions and frees up 50 sample positions for routine processing, enhancing STAT management and increasing overall sample routing flexibility. Modifications to VersaCell X3 Solution’s signature robotic arm also enable it to support both rounded and flat-bottom tubes, and the incorporation of a docking plate reduces service intervention time for all connected systems. A centralized screen on VersaCell X3 Solution provides consolidated, single-operator access to all connected analyzers, and further data consolidation is achievable through a connection to Siemens’ CentraLink Data Management System.
“Siemens strives to be a trusted partner for labs of all sizes and central to that goal is helping them identify and capitalize on their workflow excellence potential,” said Dave Hickey, CEO of the IT Business Unit at Siemens Healthcare Diagnostics. “The introduction of VersaCell X3 Solution is yet another way Siemens delivers on this mission through its ability to help labs streamline nonautomated environments and enhance operational efficiency, all at a cost they can justify.”
Related Links:
Siemens Healthcare Diagnostics
The Siemens Healthcare Diagnostics (Tarrytown, NY, USA) is unveiling the advanced VersaCell X3 system at the Clinical Lab Expo.
The newest model of Siemens’s longstanding VersaCell System, the new VersaCell X3 Solution now offers the benefits of automation without the space or budget considerations of a track-based system. VersaCell X3 Solution’s arrival compliments the recent launch of the Siemens Aptio Automation platform, designed for the growing needs of medium- to very high-volume laboratories.
The VersaCell X3 Solution delivers several advantages. The new platform maintains its small footprint and upright design, but now connects up to three Siemens analyzers through a single robotic sample interface for increased productivity gains. By supporting a customized mix of chemistry, immunoassay and/or integrated systems and associated assay menus, VersaCell X3 Solution helps labs to reduce operator sample handling, better prioritize staff work and eliminate pre- and post-analytical processing—all through one-touch sample management.
A new priority drawer on the VersaCell X3 Solution provides eight new STAT positions and frees up 50 sample positions for routine processing, enhancing STAT management and increasing overall sample routing flexibility. Modifications to VersaCell X3 Solution’s signature robotic arm also enable it to support both rounded and flat-bottom tubes, and the incorporation of a docking plate reduces service intervention time for all connected systems. A centralized screen on VersaCell X3 Solution provides consolidated, single-operator access to all connected analyzers, and further data consolidation is achievable through a connection to Siemens’ CentraLink Data Management System.
“Siemens strives to be a trusted partner for labs of all sizes and central to that goal is helping them identify and capitalize on their workflow excellence potential,” said Dave Hickey, CEO of the IT Business Unit at Siemens Healthcare Diagnostics. “The introduction of VersaCell X3 Solution is yet another way Siemens delivers on this mission through its ability to help labs streamline nonautomated environments and enhance operational efficiency, all at a cost they can justify.”
Related Links:
Siemens Healthcare Diagnostics
Latest AACC 2013 News
- Beckman Coulter Launches Newest Version of Remisol Advance at AACC
- Beckman Coulter's New Solutions Demonstrated at 2013 AACC Annual Meeting
- Solutions Designed for Labs to Reduce Costs and Improve Productivity Showcased at the AACC Expo
- Ultrasensitive Troponin-I Assay to Be Introduced at the AACC Clinical Lab Expo
- Customized Assays Assembled Using Digital Molecular Barcoding Chemistry
- Customized Monoclonal Antibody Design Highlighted at the AACC Clinical Lab Expo
- Advanced Hospital Robot Courier Debuts at the AACC Clinical Lab Expo
- Researchers Will Have Ready Access to Molecular Diagnostics Expertise at the AACC Clinical Lab Expo
- Hybrid Random Access Analyzer on Display at AACC's Clinical Lab Expo
- DCN Diagnostics and Asahi Kasei Fibers Launch Market Collaboration
- Quantitative Test for ß-Hydroxybutyrate Assesses Diabetic Ketoacidosis
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more